جستجوی مقالات مرتبط با کلیدواژه « developmental toxicity » در نشریات گروه « پزشکی »

Berberis vulgaris and berberine, its main component, traditionally have been used for treatment of various disorders. The pharmacological properties of them have been investigated using different in vivo and in vitro models. In spite of beneficial effects of B. vulgaris on different cell lines, there are documents have revealed negative impacts of it on animal and human. In this regards, the determination of its toxicity in a scientific view is necessary. In current report, we provide classified information about the toxicity of B. vulgaris and berberine in different conditions consist of acute, sub-acute, sub-chronic and chronic state. Besides, it discusses the cytotoxicity, genotoxicity, mutagenicity, and carcinogenicity of B. vulgaris and berberine as well as developmental toxicity and clinical studies. Data from the present study indicate that their toxicity is depending on the route and duration of administration. According to present study, they could induce GI upset and ulceration, immunotoxicity, phototoxicity, neurotoxicity, cardiotoxicity and jaundice in a dose dependent manner. They should be used with caution in pregnancy, neonatal and G6PD deficiency. Besides, consideration should be taken in co-administration of berberine with drugs that are metabolized with CYP enzymes due their inhibitory effects on these enzymes. Furthermore, they evoke cytotoxicity on both normal and cancer cell line which is time and concentration dependent.

Perfluorooctanesulfonate (PFOS) is a widely spread environmental contaminant. It accumulates in the brain and has potential neurotoxin effects. Due to chemical properties, PFOS shows persistency in the environment and therefore has potential hazardous effect. The risk of possible intra uterine exposure to PFOS poses a health concern for developmental effects. The goal of this study was survey of histological and behavioral changes made by PFOS in pregnant mice and their fetuses using common behavioral assays and H&E staining. In the present study doses of PFOS (1,10,20 mg/kg) given orally to pregnant mouse from gestational day (GD) 0 to GD14; then on the day 15, Behavioral experiments including (open field and passive avoidance) were used to assess toxic behavioral changes such as memory impairment and anxiety. After behavioral evaluations fetuses were dissected on day 15 of gestation and morphological and histological studies on pregnant mouse brain and her fetus were carried out using haematoxylin-eosin staining method. Our findings showed that PFOS can induce neurotoxicity in pregnant mouse especially by induction of abnormalities in dentate gyrus of hippocamps and disruption of neurobehavioral functions .Besides in her fetus; PFOS produced significant changes in brain, liver and thyroid gland in comparison with untreated control mouse fetus. As a conclusion, PFOS can cause both neurobehavioral and developmental toxicity in pregnant mouse and her fetus.